Johnson & Johnson revenue increased from $81.6 billion in 2018 to $82.1 billion in 2019, a (0.6%) increase.

Annual Revenue ($)

Johnson & Johnson revenue was $82.06 b in FY, 2019 which is a (0.6%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019
Revenue$76.45 b$81.58 b$82.06 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$17.77 b$18.84 b$19.65 b$20.01 b$20.83 b$20.35 b$20.02 b$20.56 b$20.73 b$20.69 b$18.34 b$21.08 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Johnson & Johnson revenue breakdown by business segment: 31.6% from Medical Devices, 51.4% from Pharmaceutical and 16.9% from Consumer

Johnson & Johnson revenue breakdown by geographic segment: 19.0% from Asia-Pacific, Africa, 7.2% from Western Hemisphere excluding US, 22.5% from Europe and 51.3% from United States

FY, 2019FY, 2018FY, 2017
Consumer$13.9 b$13.85 b$13.6 b
Pharmaceutical$42.2 b$40.73 b$36.26 b
Medical Devices$25.96 b$26.99 b$26.59 b
FY, 2019FY, 2018FY, 2017
United States$42.1 b$41.88 b$39.86 b
Europe$18.47 b$18.75 b$17.13 b
Western Hemisphere excluding US$5.94 b$6.11 b$6.04 b
Asia-Pacific, Africa$15.56 b$14.83 b$13.42 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu